Click to increase image sizeClick to decrease image size FundingThis work was supported in part by NIH K23DC011279 (F. Lin), the Eleanor Schwartz Charitable Foundation (F. Lin), a Triological Society/American College of Surgeons Clinician Scientist Award (F. Lin), and NIA P50-AG005146 (M. Albert).DisclosuresDr Lin reports being on the scientific advisory board of Pfizer and Autifony Therapeutics, a consultant to Cochlear Ltd, and a speaker for Med El and Amplifon. Dr Albert reports being a consultant to Agenebio, Genentech, Eisai and Eli Lilly.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: